Adalimumab-induced lethal hepatitis B virus reactivation in an HBsAg-negative patient with clinically resolved hepatitis B virus infection

Liver Int. 2010 Sep;30(8):1241-2. doi: 10.1111/j.1478-3231.2010.02238.x. Epub 2010 Mar 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Arthritis, Rheumatoid / drug therapy*
  • Fatal Outcome
  • Female
  • Hepatitis B Surface Antigens
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / physiology*
  • Humans
  • Liver / pathology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Virus Activation / drug effects*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Hepatitis B Surface Antigens
  • Tumor Necrosis Factor-alpha
  • Adalimumab